semaglutide cardiovascular outcomes study 2025 news New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss 🔴Cardiovascular outcomes with semaglutide by
Description
These medicines mimic a natural gut hormone, stimulating insulin release only when blood sugar is elevated, which reduces the risk of dangerously low glucose levels
doi:10.3390/nu13103665 Li MF, Zhou XM, Li XL

Regular movement, enough sleep, and managing stress all help your natural hunger and fullness signals, too

Wegovy is now the first once-weekly weight loss drug approved for adolescents

Researchers have been able to show that GLP-1 diminishes post-meal glucose excursions in type-1 diabetes patients and GLP-1 increases glucose disposal in an insulin independent manner

Heart and kidney benefits are seen with longer-term use
